UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022673
Receipt number R000026133
Scientific Title A Prospective Cohort Study on the usefulness of contrast-enhanced harmonic endoscopic ultrasonography (CH-EUS) in differential diagnosis of Pancreatic tumors.
Date of disclosure of the study information 2016/06/09
Last modified on 2018/10/02 12:43:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Prospective Cohort Study on the usefulness of contrast-enhanced harmonic endoscopic ultrasonography (CH-EUS) in differential diagnosis of Pancreatic tumors.

Acronym

Usefulness of contrast-enhanced harmonic endoscopic ultrasonography (CH-EUS)

Scientific Title

A Prospective Cohort Study on the usefulness of contrast-enhanced harmonic endoscopic ultrasonography (CH-EUS) in differential diagnosis of Pancreatic tumors.

Scientific Title:Acronym

Usefulness of contrast-enhanced harmonic endoscopic ultrasonography (CH-EUS)

Region

Japan


Condition

Condition

Pancreatic tumors

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the usefulness of contrast-enhanced harmonic endoscopic ultrasonography (CH-EUS) in differential diagnosis of pancreatic tumors.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase



Assessment

Primary outcomes

To assess the diagnostic ability of CH-EUS in differential diagnosis of pancreatic tumors.

Key secondary outcomes

To compare the diagnostic ability of CH-EUS with that of conventional B-mode EUS and multidetector-row computed tomography (MDCT).
To assess the diagnostic ability of CH-EUS with TIC analysis in differential diagnosis of pancreatic tumors.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

CH-EUS

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)Patients depicted Pancreatic mass using conventional EUS.
2)ECOG performance status = 0-1
3)Patients with adequate function of major organs
4)Patients who have provided written informed consent for participation in this study.

Key exclusion criteria

1)The patients who had an allergy to the contrast agent, Sonazoid.
2)The patients who had severe or uncontrolled concomitant systemic disorder.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hironari Kato

Organization

Okayama university hospital

Division name

Gastroenterology and hepatology

Zip code


Address

2-5-1, Shikata-cho, kita-ku, Okayama

TEL

086-235-7219

Email

katou-h@cc.okayama-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Naoki Yamamoto

Organization

Okayama university hospital

Division name

Gastroenterology and hepatology

Zip code


Address

2-5-1, Shikata-cho, kita-ku, Okayama

TEL

086-235-7219

Homepage URL


Email

Naokihiko@gmail.com


Sponsor or person

Institute

Okayama university hospital Gastroenterology and hepatology

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

岡山大学病院(岡山県)


Other administrative information

Date of disclosure of the study information

2016 Year 06 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 12 Month 20 Day

Date of IRB


Anticipated trial start date

2011 Year 12 Month 20 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 06 Month 09 Day

Last modified on

2018 Year 10 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026133


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name